NEW YORK, Aug. 12 - Andrew Whiteley's first day as CEO of InforMax, on April 1, happened also to be the first day of the company's fiscal second quarter. Three months later, after laying off 15 percent of its staff, InforMax went on to post barely $4 million in receipts--a 50-percent drop from last year's second quarter--and book $6.5 million in net losses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.